AsoGen Therapeutics IVS

CVR 40357092 · Entrepreneurial company (IVS) · Dissolved after voluntary liquidation

AsoGen Therapeutics IVS is a Entrepreneurial company (IVS), founded on , based in Odense S. The company is registered in the industry fremstilling af farmaceutiske præparater. The company is no longer active (status: dissolved after voluntary liquidation). 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2020) shows equity of DKK -56k and a net result of DKK -39k.

Company details

CVR number
40357092
Status
Dissolved after voluntary liquidation
Company type
Entrepreneurial company (IVS)
Founded
Ceased
Address
c/o HM Holding ApS, Sivlandvænget 3, 1.
5260 Odense S
Municipality
Odense
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 200
Auditor
PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 2
Missing annual reportNo
Negative equityYes
Equity ratio-23.4%
Current ratio127%
Moves (last 2 years)1
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address34
Going-concern uncertaintyYes

Financials and key figures

Financial year20202019
Gross profitDKK -7,007DKK -5,000
Net profitDKK -39kDKK -17k
EquityDKK -56kDKK -16k
Total assetsDKK 238kDKK 265k
CashDKK 21k–
Short-term debtDKK 23k–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2020 – 31 Dec 2020188 Late
15 Mar 2019 – 31 Dec 2019160

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMarkus Sakari Kauppinen
BoardMads Spangaard Rasmussen
BoardMarkus Sakari Kauppinen
Owner (100%)AsoGen Holding IVS
FounderAsoGen Holding IVS

The CEOs' other companies

Markus Sakari Kauppinen – 4 other companies

Address history (1 moves)

c/o HM Holding ApS, Sivlandvænget 3, 1., 5260 Odense S
c/o Fonden for Syddansk Vækstfremme, Vestergade 26, 6500 Vojens

Other companies at the same address

Similar companies in Odense

Questions and answers about AsoGen Therapeutics IVS

Has AsoGen Therapeutics IVS gone bankrupt?

No, AsoGen Therapeutics IVS is not registered as bankrupt in the CVR register. Its status is: dissolved after voluntary liquidation.

Who is the auditor of AsoGen Therapeutics IVS?

AsoGen Therapeutics IVS most recently used PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

When was AsoGen Therapeutics IVS founded?

AsoGen Therapeutics IVS was founded on 15 March 2019.

What is the equity of AsoGen Therapeutics IVS?

Equity was DKK -56k according to the annual report for the period ending 31 December 2020.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.